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Background: Extensive research on bone tissue engineering as a novel therapeutic 
approach to design and fabricate suitable scaffolds is in progress to overcome the 
limitations of conventional bone repair techniques. In recent years, tissue 
engineering and remedial medicine have come up with the strategy of designing, 
fabricating, and optimizing synthetic and natural scaffolds containing cells and 
growth factors to facilitate the direct and indirect mechanisms of bone tissue repair 
in the body. Based on many studies, cellular source, cell medium condition, and 
biological scaffolds are critical factors in bone defect repair in the field of tissue 
engineering.  
 
Aim: In this review, we focus on the combination of mesenchymal cells derived 
from the human adipose tissue, stem cell-to-bone differentiation medium, and 
biocompatible polyvinyl alcohol-graphene oxide scaffolds in bone lesion repair to 
gain a better understanding of each factor. This would, in turn, help us design and 
develop optimal therapeutic approaches for bone repair and regeneration. 
 
Conclusion: The combination of mesenchymal cells and biocompatible scaffolds 
proved promising in the process of bone lesion repair. 
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Introduction 
Nowadays, advances in medical science have 
increased life expectancy. However, this 
increase has led to the new challenge of the 
high prevalence of age-related diseases 
thereby reducing the quality of life. Loss of 
skeletal tissue as a result of trauma or skeletal 
degenerative diseases (scoliosis, osteoporosis, 
osteoarthritis, infection, and tumors) has 
dramatically elevated the mortality rates and 
socio-economic costs. Along with the 
increasing quality of life and life expectancy in  
 
today's societies, bone lesions and their 
complications have also grown substantially. 
Nevertheless, conventional methods of 
repairing these lesions are not responsive to 
the medical needs of these patients due to their 
limitations.  
Although various techniques have been 
proposed in the past few years to treat bone 
lesions, this is still one of the major challenges 
in orthopedics (1).  
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Conventional bone repair approaches 
Bone transplantation is the second most 
common type of transplant following blood 
transplantation in the world (2). Despite the 
long history of bone marrow transplantation as 
a standard treatment for bone lesions, the 
application of this treatment has been limited 
due to several constraints. The autograft 
technique (the patient's own source) which has 
been the gold standard method for treating 
bone lesions also poses challenges such as 
restricting the area, increasing the risk of 
injury at the supplier site, the risk of new 
fractures, the likelihood of transplant failure, 
and the need for surgery. Secondly, the 
allograft technique (human source) and the 
xenograft (animal source) also face the 
challenge of transplant rejection and pathogen 
transmission (3-5). The two common treatment 
approaches for bone lesions are metal implant 
strategies (titanium and steel alloys) and 
iron/plum graft techniques, both of which have 
their specific defects and may be associated 
with complications including implant 
movement, inflammation, bone resorption, 
long-term surgery, transplant deficiency, 
transplant rejection problems, and 
transmission of pathogens. The metal implants 
(joint prosthesis, bolts) are most commonly 
used for structural and mechanical support of 
arthroplasty and long bone fractures whose 
most important limitations are lack of 
biodegradability, high hardness, fatigue, 
fracture, failure to integrate into the host 
tissue, protrusion, and infection. The 
limitations of these therapeutic approaches 
along with the societies’ growing need for 
efficient therapies have encouraged 
researchers to develop new therapeutic 
strategies to restore or replace damaged 
skeletal tissues. 
 
Tissue engineering-based therapeutic 
approaches 
In recent years, tissue engineering and 
remedial medicine have come up with 
strategies for designing, manufacturing, and 
optimizing synthetic and natural scaffolds 
containing cells and growth factors to 
eliminate the side effects of traditional 
therapies. Due to the growing need for tissue 
transplants and the lack of appropriate donors, 
tissue engineering-based therapeutic strategies 
are increasingly being considered as a 
promising approach. The key factors in the 
success of tissue engineering-based therapeutic 
strategies include the cellular source and 
optimal culture medium with biological and 
biodegradable scaffolds (6, 7).  
 Cellular Source 
The cellular source is one of the challenges in 
tissue engineering which requires specific 
optimization. Today, the potential of stem cell-
based therapies in the repair and restoration of 
living tissues has been considered as a novel 
therapeutic solution and an alternative to 
traditional methods of treatment. The use of 
embryonic stem cells (ESCs) and induced 
pluripotent stem cells (iPSC) has many 
advantages; however, due to the lack of 
precise regulation of the regulatory cycle, as 
well as technical and ethical problems in 
genetic isolation and manipulation, its 
application is currently limited (8). The 
mesenchymal stem cells (non-blood cells 
derived from embryonic mesoderm) are 
another source of stem cells that have valuable 
stem cell characteristics such as self-renewal 
and in vitro replication, differentiation into 
specialized cells (bone, cartilage, muscle, 
tendon, etc.), easy accessibility and 
separability from various autologous and 
allogeneic sources (bone, cartilage, muscle, 
tendon, ligament, embryonic structures, etc.) 
which could be a suitable cell candidate in 
reconstructive medicine (9-16). Although 
mesenchymal cells isolated from various 
sources have many advantages, limitations in 
the number of available cells and inadequate 
access to the amount of tissue required for 
cellular extraction have limited their 
therapeutic processes. Adipose-derived stem 
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cells, however, do not impose these 
limitations. Adipose tissue and its 
mesenchymal cells are readily accessible 
without the risk of patient injury or death and 
can be used as an autologous cell source in 
research and clinical phases (8). Based on 
studies of adipose tissue-derived mesenchymal 
cells (ADSCs) in humans (17, 18) and mice 
(19), they have been able to acquire the 
characteristics of differentiated (morphological 
and functional) metastatic cells such as in vitro 
extracellular matrix calcium phosphate, 
expression of osteoblast-specific proteins 
(osteocalcin and alkaline phosphatase) and 
response to mechanical stress (increased 
expression of alkaline phosphatase, 
osteocalcin, collagen type Ia1 and COX2) and 
shear stress of fluids. These results suggest 
that adipose tissue-derived mesenchymal cells 
have the potential to differentiate into 
mechanical stress-sensitive bone cells and are 
considered as valuable cellular candidates in 
bone tissue engineering (17, 18, 20, 21). 
Transcription factors affecting the 
differentiation of ADSCs into bone marrow 
cells have not been fully identified, but the 
effective roles of Menin, Shh, Notch-1, BMP2, 
RunX2, TBX3, and valproic acid have been 
reported (22-27). FGF2 has also been 
confirmed as an inhibitor of the differentiation 
of ADSCs into bone marrow cells (28). 
Another prominent feature of these cells is the 
secretion of growth factors required for the 
indirect repair of bone lesions such as VEGF, 
HGF, IGF-1, and TNFα (8, 17). No specific 
markers have been reported for these cells so 
far, and their differentiation from fibroblast 
cells is very challenging for researchers. 
Generally, mesenchymal cells have no or low 
level of expression of hematopoietic markers 
including CD11b, CD14, and CD19, CD34, 
CD45, CD79a, CD117, HLA-DR, CD73, 
CD90, and CD105. In addition to the 
importance of specific differentiation factors 
of ADSCs to bone cells, synthetic extracellular 
matrix and three-dimensional cell culture 
medium are other essentials of the cell 
differentiation process (5, 7). Note that, in the 
field of bone tissue engineering, animal cells 
have been mostly used in research and further 
studies using human cells are required as well. 
The application of tissue engineering scaffolds 
with human cells also needs to be further 
validated in pre-clinical studies to step into the 
next phases of clinical research.  
 Culture medium optimization 
Culture conditions and optimum culture 
medium are other influential parameters in 
living tissue engineering, which is currently 
undergoing extensive research to improve the 
culture conditions of these cells and to provide 
suitable differentiation environments. Culture 
media containing dexamethasone, ascorbic 
acid, beta-glycerophosphate, valproic acid, 
vitamin D3, and BMP-2 are commonly used to 
differentiate adipose tissue mesenchymal stem 
cells (8). The transcription factors, specific 
genes, and functional proteins that are 
involved in the process of stem cell 
differentiation to specific bone cells can be 
examined to confirm cellular differentiation. 
The most important molecular properties of an 
osteoblast-differentiated cell include the ability 
of mineralization, cell membrane-dependent 
alkaline phosphatase activity, bone matrix 
molecules such as type I collagen (COLL I), 
osteocalcin, bone cysteoprotein, and bone 
sialoprotein (BSP), and BSP parathyroid-
dependent growth factors which are all 
influenced by the key transcription factor 
Runx2, regulating the morphology of 
osteoblasts. In addition to the Runx2 
transcription factor, the molecules that are 
involved in various signaling pathways such as 
TGF-1, BMP, Wnt, HH, and NELL-1 are also 
required to complete the differentiation stage 
of these cells (8, 17, 28). 
 Biological and biodegradable scaffold 
Another requirement in the field of tissue 
engineering is the design and manufacture of 
scaffolds. Most scaffolds used for bone tissue 
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engineering are made of polymers, bioactive 
ceramics, composites (hybrids), depending on 
their application type (solid scaffold or 
injectable scaffold). Three-dimensional (3D) 
scaffolds are used in various in vitro and in 
vivo studies which are usually made of natural 
polymers such as those in extracellular matrix 
proteins including collagen, fibrin, elastin, 
hyaluronic acid. Alternatively, they could be 
synthetic polymers such as various 
macroalcohols including polyethylene glycol, 
polycaprolactone, polyvinyl alcohol, or a 
combination of two groups. In the field of 
bone tissue engineering, three-dimensional 
micro- or nanostructured scaffolds with a pore 
size between 100 μm and 350 μm and 
permeability of over 90% have been typically 
used for various materials and fabrication 
methods (29).  
These scaffolds typically support the 
attachment of extracellular matrix cells and 
proteins to the surface and provide a suitable 
biological environment for the proliferation, 
differentiation, cell migration, and secretion of 
extracellular matrix proteins as well as the 
targeted release of biomolecules, along with 
active and controlled nutrients at the right time 
and in the desired space. The toxicity, 
immunogenicity, biocompatibility, 
biodegradability, and mechanical properties of 
3D scaffolds are important factors. Thanks to 
the desired mechanical and physicochemical 
properties of the polyvinyl alcohol hydrogel 
polymer and its wide application in bone tissue 
engineering research, this compound has been 
recently used as the main basis of scaffold 
construction; in this regard, polyvinyl alcohol-
graphene oxide hydrogel nanocomposites can 
also be used for scaffold fabrication (30). 
Polyvinyl alcohol (PVA) is a synthetic, non-
toxic, non-carcinogenic, water-soluble, 
biocompatible and bioadhesive hydrogel 
polymer with favorable physicochemical 
properties which provides extracellular matrix 
topography very well. This FDA-approved 
polymer has been widely used in orthopedic 
implants and other medical applications such 
as contact lenses, artificial pancreas, 
hemodialysis, and so on.  
PVA is a linear carbon polymer with a 
hydroxyl group in the side chain which is well 
capable of forming fibrous forms and 
combining with other polymers. This synthetic 
polymer is formed from partial hydrolysis to 
complete polyvinyl acetate and removal of 
acetate groups (31, 32). 
The degree of PVA hydroxylation determines 
its physical, chemical, and mechanical 
properties. This polymer dissolves in water 
well, but it is resistant to most organic 
solvents. The higher the degree of 
hydroxylation of this polymer, the lower its 
solubility in water and the more crystalline it 
becomes. As such, they are crosslinked in the 
form of cross hydrogels to be used for 
different purposes. The cross-linking of this 
polymer with chemical or physical agents 
enhances its structural strength when 
absorbing water or biological fluids. The 
degree of crosslinking of PVA hydrogels 
determines the rate of water uptake followed 
by its physical, chemical, diffusion, and 
biological properties. In addition to the cross-
linking degree of PVA hydrogel, its molecular 
weight and concentration also affect its final 
properties (32, 32). The PVA polymer is 
crosslinked with various agents such as 
Genipin, citric acid, glyoxal, glutaraldehyde, 
UV, borax vanadate (Na tetraborate, 
Na2B4O7, etc.). The structural and physical 
properties of polyvinyl alcohol-borax aqueous 
composition have been extensively studied. 
The cross-linking reaction occurs between 
PVA and borate ion, which is called the di-diol 
compound in which two PVA hydroxyl ions 
are combined with one borate ion. The cross-
linking degree of PVA with borax can be 
easily adjusted by altering the concentration 
and molecular weight of PVA and borax, 
where a reversible gel is produced with 
favorable physicochemical properties (33-37). 
3D scaffolds made of chitosan, fibrin, and 
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tricalcium phosphate, and PVA have been 
reported as a suitable scaffold for 
differentiating ADSCs into bone cells (5, 7). 
Graphene oxide-polyvinyl alcohol composite 
along with other natural and synthetic 
polymers have been widely used in bone tissue 
engineering. Recent studies have suggested 
that graphene oxide not only optimizes the 
physicochemical properties of the composites 
but also reduces the diameter of nanofibers 
and creates a suitable surface for cell 
attachment and proliferation. Further, it 
stimulates the osteogenesis in mouse bone 
marrow mesenchymal cells.  
Ethylene polytetrafluoroethylene (PTFE) also 
provides a porous structure and a suitable 
surface for connecting and regenerating bone 
cells. Carbon polytetrafluoroethylene or 
Teflon is a thermoplastic polymer consisting 
of an ethylene framework with four fluorine 
groups (two fluorine groups per carbon atom). 
The presence of fluorine groups and the strong 
bonding of carbon and fluorine with this 
polymer is very important. Accordingly, PTFE 
is a stable polymer that is biologically neutral 
and chemically inactive. PTFE is a tough, 
flexible material with moderate tensile 
strength, heat resistance, and chemical 
properties. This polymer has the low abrasion 
resistance and excellent thermal stability up to 
300° C, but it decomposes at over 350° C. 
PTFE is a neutral biomaterial with a low 
coefficient of friction. In 2008, Jeongand 
colleagues investigated the repair of scaffold 
hybrid chondrocytic lesions composed of 
polydioxanone-polyvinyl alcohol by melt-
molding particulate-leaching method 
containing human bone marrow mesenchymal 
cells. Based on the successful results of the in 
vitro study, scaffolds containing rabbit bone 
marrow mesenchymal cells were also studied 
in vivo (27). The team reported that 
MSC / PDO / PVA hybrid scaffold created a 
new cartilage tissue in vitro and improved 
osteochondral lesion repair in vivo (27). 
In 2009, Asran and colleagues prepared an 
electrophoretic nanofiber scaffold made of 
polyvinyl alcohol-collagen type I-nano-
hydroxyapatite and proposed it for bone tissue 
engineering due to the physicochemical 
properties of the scaffolds (38). Qu and 
colleagues (2010) prepared a bilayer 
osteochondral scaffold using polyvinyl 
alcohol-gelatin-nanohydroxyapatite-polyamide 
6 to repair cartilage and bone lesions and post-
implantation of bone marrow-derived 
mesenchymal stem cells. They were implanted 
in an ectopic area in rabbits. This group 
suggested scaffolds for bone and cartilage 
tissue engineering (39).  
In 2010, Nitzscheand colleagues developed a 
composite scaffold containing collagen I-
chitosan-hydroxyapatite-polyvinyl alcohol in 
the freeze-drying method and applied it in 
bone tissue engineering (40). Zhang and 
colleagues in 2011 developed a polyvinyl 
alcohol-nano graphene oxide composite by 
melting-freezing. They observed a 132% 
increase in tensile strength and 32% in 
compressive strength of PVA compared to 
pure PVA hydrogel in response to adding 
0.8% wt of graphene oxide. Note that the 
addition of this amount of GO had no effect on 
PVA toxicity on osteoblast cells (41).  
In 2011, Qi and his colleagues developed a 
nanofiber composite using the electrospinning 
method composed of polyvinyl alcohol-
graphene oxide. They observed a decrease in 
the fiber diameter, an increase in tensile 
strength (less than 1% wt GO), and binding 
and growth of murine osteoblast cells 
(MC3T3-E1) on the scaffold without affecting 
the viability (42). Depan and colleagues 
reported that the presence of graphene oxide in 
chitosan nanocomposite structure enhances the 
proliferation and growth of osteoblasts and 
improves cell-scaffold and cell-cell 
interactions. It also improves the mechanical 
and physicochemical properties of the scaffold 
(43). The graphene and graphene oxide 
demonstrated to affect the growth and 
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differentiation of mesenchymal cells in terms 
of the type of bonding interaction (covalent, 
electrostatic, or hydrogen) with the surface of 
mesenchymal cells. Also, graphene and 
graphene oxide has been identified as effective 
inducers of bone marrow mesenchymal cells to 
the osteocyte cell line. According to this study, 
graphene inhibits chondrocyte differentiation 
pathway due to its specific interaction with 
insulin, while graphene oxide does not 
interfere with this process (44). 
In 2012, Wang and his colleagues fabricated 
polyvinyl alcohol-graphene oxide nanofibers 
by electrospinning. Elsewhere, Chahal and 
colleagues utilized cellulose nanofibers and 
polyvinyl alcohol to fabricate suitable bone 
tissue engineering scaffolds by 
electrospinning. They found that the spinning 
conditions of cellulose improved and their 
mechanical properties increased after the 
addition of PVA (45,46). 
In 2013, Pandele and his colleagues developed 
a casting method for chitosan-polyvinyl 
alcohol-graphene oxide nanocomposites (47). 
 
Conclusion: 
The combination of mesenchymal cells and 
biocompatible scaffolds proved promising in 
the process of bone lesion repair. 
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